Literature DB >> 26677443

Carcinoma of unknown primary and paraneoplastic dermatomyositis.

Amir Sonnenblick1.   

Abstract

Dermatomyositis is known to be associated with neoplastic disorders, however the presentation of carcinoma of unknown primary as dermatomyositis is rare. We describe a case index of 50-year-old female who presented with enlarged inguinal lymph nodes accompanied with symmetric proximal muscle weakness and erythematous plaques. Conventional basic work-up did not reveal the diagnosis, however, positron emission tomography-computed tomography and re-staining of the pathology specimen suggested the ovaries as the primary site. Chemotherapy including carboplatin paclitaxel and bevacizumab led to complete response of disease and improvement in the dermatomyositis. The present case emphasizes the importance of a thorough directed evaluation for the underlying cancer in patients with carcinoma of unknown primary presenting as dermatomyositis. We further provide an up-to-date detailed review of published data describing these clinical entities.

Entities:  

Keywords:  Cancers of unknown primary; Dermatomyositis; Paraneoplastic; Positron emission tomography

Year:  2015        PMID: 26677443      PMCID: PMC4675915          DOI: 10.5306/wjco.v6.i6.295

Source DB:  PubMed          Journal:  World J Clin Oncol        ISSN: 2218-4333


  17 in total

1.  Dermatomyositis associated with malignancy. 12 case reports.

Authors:  L A Dourmishev
Journal:  Adv Exp Med Biol       Date:  1999       Impact factor: 2.622

2.  Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study.

Authors:  B Sigurgeirsson; B Lindelöf; O Edhag; E Allander
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

Review 3.  Dermatomyositis and malignancy. A review of the literature.

Authors:  B E Barnes; B Mawr
Journal:  Ann Intern Med       Date:  1976-01       Impact factor: 25.391

4.  Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study.

Authors:  C L Hill; Y Zhang; B Sigurgeirsson; E Pukkala; L Mellemkjaer; A Airio; S R Evans; D T Felson
Journal:  Lancet       Date:  2001-01-13       Impact factor: 79.321

5.  Conventional cancer screening versus PET/CT in dermatomyositis/polymyositis.

Authors:  Albert Selva-O'Callaghan; Josep M Grau; Cristina Gámez-Cenzano; Antonio Vidaller-Palacín; Xavier Martínez-Gómez; Ernesto Trallero-Araguás; Eduard Andía-Navarro; Miquel Vilardell-Tarrés
Journal:  Am J Med       Date:  2010-06       Impact factor: 4.965

6.  Paraneoplastic syndromes: detection of malignant tumors using [(18)F]FDG-PET.

Authors:  U Berner; C Menzel; D Rinne; S Kriener; N Hamscho; N Döbert; M Diehl; R Kaufmann; F Grünwald
Journal:  Q J Nucl Med       Date:  2003-06

7.  Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis.

Authors:  Rainer Linke; Mira Schroeder; Thomas Helmberger; Raymond Voltz
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

8.  FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes.

Authors:  S Younes-Mhenni; M F Janier; L Cinotti; J C Antoine; F Tronc; V Cottin; P J Ternamian; P Trouillas; J Honnorat
Journal:  Brain       Date:  2004-09-10       Impact factor: 13.501

9.  FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.

Authors:  Ronald Boellaard; Mike J O'Doherty; Wolfgang A Weber; Felix M Mottaghy; Markus N Lonsdale; Sigrid G Stroobants; Wim J G Oyen; Joerg Kotzerke; Otto S Hoekstra; Jan Pruim; Paul K Marsden; Klaus Tatsch; Corneline J Hoekstra; Eric P Visser; Bertjan Arends; Fred J Verzijlbergen; Josee M Zijlstra; Emile F I Comans; Adriaan A Lammertsma; Anne M Paans; Antoon T Willemsen; Thomas Beyer; Andreas Bockisch; Cornelia Schaefer-Prokop; Dominique Delbeke; Richard P Baum; Arturo Chiti; Bernd J Krause
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

10.  Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002).

Authors:  R Bugat; A Bataillard; T Lesimple; J J Voigt; S Culine; A Lortholary; Y Merrouche; G Ganem; M C Kaminsky; S Negrier; M Perol; C Laforêt; P Bedossa; G Bertrand; J M Coindre; K Fizazi
Journal:  Br J Cancer       Date:  2003-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.